Investec Bank plc has filed a Form 8.5 regulatory disclosure revealing significant share dealings in Advanced Medical Solutions Group plc (AMS.L) on 11th June 2026.
The disclosure was made under Rule 8.5 of the Takeover Code, which governs public dealing disclosures by exempt principal traders with recognised intermediary status.
Investec Bank plc acted in a client-serving capacity during the dealings, a standard arrangement for institutions operating as exempt principal traders under the Code.
Investec is identified in the filing as Advisor and Joint Broker to Advanced Medical Solutions Group plc, establishing its connected status to the offer party.
The bank purchased a total of 164,779 ordinary shares in Advanced Medical Solutions Group, with prices ranging between 223 and 225 pence per unit.
On the same date, Investec also sold 189,967 ordinary shares in the company, again at prices ranging between 223 and 225 pence per unit.
The volume of shares sold exceeded the volume purchased, with sales outpacing purchases by approximately 25,000 shares across the session.
No cash-settled derivative transactions, stock-settled derivative transactions, or options activity was reported as part of this disclosure filing.
Investec confirmed there are no indemnity arrangements, option agreements, or understandings that could represent an inducement to deal or refrain from dealing.
The bank also confirmed no agreements or understandings exist relating to voting rights or future acquisition and disposal of securities linked to any derivative instrument.
The disclosure was formally dated 12th June 2026, with contact for the filing attributed to Abhishek Gawde, reachable via the telephone number listed in the regulatory submission.
Public disclosures of this nature under Rule 8 of the Takeover Code are required to be submitted to a Regulatory Information Service in a timely manner.
